Is It Worth Considering Anhui Hongyu Wuzhou Medical Manufacturer Co.,LTD. (SZSE:301234) For Its Upcoming Dividend?
Is It Worth Considering Anhui Hongyu Wuzhou Medical Manufacturer Co.,LTD. (SZSE:301234) For Its Upcoming Dividend?
Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be intrigued to know that Anhui Hongyu Wuzhou Medical Manufacturer Co.,LTD. (SZSE:301234) is about to go ex-dividend in just 2 days. Typically, the ex-dividend date is one business day before the record date which is the date on which a company determines the shareholders eligible to receive a dividend. The ex-dividend date is of consequence because whenever a stock is bought or sold, the trade takes at least two business day to settle. In other words, investors can purchase Anhui Hongyu Wuzhou Medical ManufacturerLTD's shares before the 25th of June in order to be eligible for the dividend, which will be paid on the 25th of June.
一些投資者依靠分紅來增加財富,如果你是這些投資者之一,你可能會對知道,安徽宏宇五洲醫療製品股份有限公司 (SZSE:301234) 即將在2天內除權息感到感興趣。通常,除息日是股東能夠享有分紅的日期前的一個工作日。除息日的影響在於,無論何時買入或賣出一股股票,交易至少需要兩個工作日來結算。換句話說,投資者可以在6月25日前買入安徽宏宇五洲醫療製品股份有限公司股票以享受分紅,該公司將於6月25日支付分紅。
The company's upcoming dividend is CN¥0.40 a share, following on from the last 12 months, when the company distributed a total of CN¥0.40 per share to shareholders. Looking at the last 12 months of distributions, Anhui Hongyu Wuzhou Medical ManufacturerLTD has a trailing yield of approximately 1.9% on its current stock price of CN¥21.54. Dividends are a major contributor to investment returns for long term holders, but only if the dividend continues to be paid. As a result, readers should always check whether Anhui Hongyu Wuzhou Medical ManufacturerLTD has been able to grow its dividends, or if the dividend might be cut.
該公司即將派發0.40元人民幣每股的股息,此前12個月該公司向股東派發了總共0.40元人民幣每股的股息。回顧過去12個月的派息,安徽宏宇五洲醫療製品股份有限公司的股息率大約是1.9%。僅當股息繼續派發時,股息才會是長揸人的最大貢獻。因此,讀者應始終檢查安徽宏宇五洲醫療製品股份有限公司是否能夠增加股息,或者股息是否會被減少。
Dividends are typically paid out of company income, so if a company pays out more than it earned, its dividend is usually at a higher risk of being cut. Anhui Hongyu Wuzhou Medical ManufacturerLTD paid out a comfortable 48% of its profit last year. Yet cash flows are even more important than profits for assessing a dividend, so we need to see if the company generated enough cash to pay its distribution. It paid out more than half (73%) of its free cash flow in the past year, which is within an average range for most companies.
分紅通常是由公司收入支付的,因此,如果公司支付的股息超過了其賺取的利潤,公司的股息通常會面臨更高的風險被削減。去年,安徽宏宇五洲醫療製品股份有限公司支付了其利潤的舒適48%。但是,現金流比利潤對評估分紅更加重要,因此我們需要查看公司是否產生足夠的現金支付其分配。在過去的一年中,該公司支付了超過自由現金流的一半(73%),這在大多數公司中處於平均範圍內。單擊此處以查看過去12個月內安徽宏宇五洲醫療製品股份有限公司支付了多少利潤。
It's encouraging to see that the dividend is covered by both profit and cash flow. This generally suggests the dividend is sustainable, as long as earnings don't drop precipitously.
看到股息既有盈利也有現金流的覆蓋是令人鼓舞的。這通常表明股息是可持續的,只要收益沒有急劇下降。
Click here to see how much of its profit Anhui Hongyu Wuzhou Medical ManufacturerLTD paid out over the last 12 months.
單擊此處了解安徽宏宇五洲醫療製品股份有限公司在過去12個月內支付了多少利潤。
![historic-dividend](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240622/0-f6f0a4d37b457771444a1c4a76b4b0f7-0-f27dca53aa1964b8192ee0d40d5424de.png/big)
Have Earnings And Dividends Been Growing?
收益和股息一直在增長嗎?
Businesses with strong growth prospects usually make the best dividend payers, because it's easier to grow dividends when earnings per share are improving. If earnings fall far enough, the company could be forced to cut its dividend. This is why it's a relief to see Anhui Hongyu Wuzhou Medical ManufacturerLTD earnings per share are up 5.0% per annum over the last five years. Earnings per share growth has been slim, and the company is already paying out a majority of its earnings. While there is some room to both increase the payout ratio and reinvest in the business, generally the higher a payout ratio goes, the lower a company's prospects for future growth.
通常具有強勁增長前景的企業往往是最好的分紅派息者,因爲當每股收益率提高時,增加派息更加容易。如果收益率下降得足夠多,公司可能被迫削減其分紅派息份額。這就是爲什麼看到安徽紅宇五洲醫療製造有限公司過去五年中每股收益率每年增長5.0%是令人欣慰的。每股收益增長幅度較小,公司已經支付了大部分的收益。雖然在提高派息比率和再投資企業方面還有一些空間,但一般來說,派息比率越高,公司未來增長的前景就越低。
Given that Anhui Hongyu Wuzhou Medical ManufacturerLTD has only been paying a dividend for a year, there's not much of a past history to draw insight from.
考慮到安徽宏宇五洲醫療製品股份有限公司僅派發了一年的股息,因此並沒有太多歷史可以從中獲得見解。
The Bottom Line
還有一件事需要注意的是,我們已經確定了上海醫藥的2個警告信號,了解這些信號應該成爲你的投資過程的一部分。
Should investors buy Anhui Hongyu Wuzhou Medical ManufacturerLTD for the upcoming dividend? Earnings per share growth has been modest, and it's interesting that Anhui Hongyu Wuzhou Medical ManufacturerLTD is paying out less than half of its earnings and more than half its cash flow to shareholders in the form of dividends. Overall, it's not a bad combination, but we feel that there are likely more attractive dividend prospects out there.
投資者是否應該購買安徽紅宇五洲醫療製造有限公司的未來分紅派息?每股收益增長率較爲適中,有趣的是,安徽紅宇五洲醫療製造有限公司支付的分紅比其收益的一半還要少,並且將一半以上的現金流轉化向股東進行派息。總的來說,這不是一個壞的組合,但我們認爲可能還有更具吸引力的股息前景。
So while Anhui Hongyu Wuzhou Medical ManufacturerLTD looks good from a dividend perspective, it's always worthwhile being up to date with the risks involved in this stock. For example, we've found 1 warning sign for Anhui Hongyu Wuzhou Medical ManufacturerLTD that we recommend you consider before investing in the business.
因此,雖然從分紅的角度來看,安徽宏宇五洲醫療製品股份有限公司看起來不錯,但認識到該股票涉及的風險是值得的。例如,我們發現了一則關於安徽宏宇五洲醫療製品股份有限公司的警告信號,建議您在投資該公司之前加以考慮。
A common investing mistake is buying the first interesting stock you see. Here you can find a full list of high-yield dividend stocks.
一個常見的投資錯誤是購買你看到的第一個有趣的股票。在這裏,您可以找到高股息股票的完整列表。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或電郵 editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或者,也可以發送電子郵件至editorial-team@simplywallst.com